Rational design, synthesis, and serine protease inhibitory activity of novel P-1-argininoyl heterocycles

被引：23
|
作者：
Tamura, SY
Shamblin, BM
Brunck, TK
Ripka, WC
机构：
[1] Department of Medicinal Chemistry, Corvas International, Inc., San Diego, CA 92121
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 10期
关键词：
D O I：
10.1016/S0960-894X(97)00227-8
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Peptidomimetic derivatives featuring a P-1-argininoyl heterocycle were designed. The preparation of two key building blocks containing benzoxazole or benzimidazole rings and their incorporation into thrombin and factor Xa specific sequences is described. The serine protease inhibitory activity of these targets was evaluated. Molecular modeling of two representative structures is presented. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码：1359 / 1364
页数：6
相关论文
共 50 条
  • [21] Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors
    Suzuki, Takayoshi
    Tanaka, Rikako
    Hamada, Shohei
    Nakagawa, Hidehiko
    Miyata, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1124 - 1127
  • [22] NOVEL SERINE PROTEASE INHIBITORS HAVING MULTIPLE PHYSIOLOGICAL ACTIONS - SYNTHESIS, INHIBITORY ACTIVITIES TOWARD PROTEASES AND THEIR PHARMACOLOGICAL EFFECTS
    SATOH, T
    MURAMATU, M
    YANAGIMOTO, Y
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1982, 5 (04): : S51 - S51
  • [23] Design, synthesis, molecular modeling studies, and calpain inhibitory activity of novel α-ketoamides incorporating polar residues at the P1'-position
    Donkor, IO
    Han, J
    Zheng, XZ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) : 72 - 79
  • [24] Design and synthesis of novel hydroxyalkylaminomethylchromones for their IL-5 inhibitory activity
    Thanigaimalai, P.
    Lee, Ki-Cheul
    Sharma, Vinay K.
    Yun, Jun-Ho
    Kim, Youngsoo
    Jung, Sang-Hun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (13) : 4625 - 4629
  • [25] Synthesis and antimicrobial activity of novel phosphorus heterocycles with exocyclic P-C link
    Reddy, PVG
    Kiran, YBR
    Reddy, CS
    Reddy, CD
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (03) : 307 - 310
  • [26] Novel Inhibitory Activity for Serine Protease Inhibitor Kazal Type-3 (Spink3) on Human Recombinant Kallikreins
    Assis, Diego Magno
    Zalazar, Lucia
    Juliano, Maria Aparecida
    De Castro, Rosana
    Cesari, Andreina
    PROTEIN AND PEPTIDE LETTERS, 2013, 20 (10): : 1098 - 1107
  • [27] Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors
    Dudley, DA
    Bunker, AM
    Chi, LG
    Cody, WL
    Holland, DR
    Ignasiak, DP
    Janiczek-Dolphin, N
    McClanahan, TB
    Mertz, TE
    Narasimhan, LS
    Rapundalo, ST
    Trautschold, JA
    Van Huis, CA
    Edmunds, JJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (22) : 4063 - 4070
  • [28] Design and synthesis of a novel series of HIV-1 protease inhibitors
    Takashiro, E
    Nakamura, Y
    Miyamoto, S
    Ozawa, Y
    Sugiyama, A
    Fujimoto, K
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (09) : 2105 - 2114
  • [29] Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2′-ligands
    Ghosh, AK
    Schiltz, G
    Perali, RS
    Leshchenko, S
    Kay, S
    Walters, DE
    Koh, Y
    Maeda, K
    Mitsuya, H
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1869 - 1873
  • [30] Design, Synthesis, and Thrombin Inhibitory Activity Evaluation of Some Novel Benzimidazole Derivatives
    Ren, Weixin
    Ren, Yujie
    Dong, Minghui
    Gao, Yonghong
    HELVETICA CHIMICA ACTA, 2016, 99 (04) : 325 - 332
12345